Definitive Biotechnologies
Elkridge, US · Founded 2021 · Delaware LLC
Founders & leadership
PL
Peter LathamManager of the Issuer
Reported raises · per SEC filings
Form D private placements$5.2M disclosed across 2 rounds · 2021–2023
▶$900KraisedMar 2024 · 3 investors · Other Health CareRule 506(b)
▶$900KraisedMar 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter LathamExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $900K
- First sale
- Mar 2023
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 06b
▶$4.3MraisedMar 2024 · 16 investors · Other Health CareRule 506(b)
▶$4.3MraisedMar 2024 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter LathamExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $4.3M
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Definitive Biotechnologies raised?
- Definitive Biotechnologies has disclosed $5.2M raised across 2 rounds.
- Where is Definitive Biotechnologies headquartered?
- Definitive Biotechnologies is headquartered in Elkridge, US.